Polynoma-1

N/A

Report date: 2022/03/03 17:33:55

Base Information

Drug NamePolynoma-1

Drug Alias NamePolyvalent melanoma vaccine (Vaccinoma)

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionMelanoma antigen recognized by T-cells 1 modulatorsTyrosinase-related protein 1 inhibitorsMelanoma-associated antigen 3 modulators

TargetsTyrosinase-related protein 1Melanoma antigen recognized by T-cells 1Melanoma-associated antigen 3

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVaccinoma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaccinoma

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A